Cannabis use disorder

A study found that nearly 34% of adolescents seeking treatment for cannabis use disorder (CUD) in 2022 experienced admission delays, with wait times increasing sharply after 2020. The research, published in the American Journal of Preventive Medicine, analyzed over 124,000 adolescent admissions between 2012 and 2022, linking delays to post-pandemic disruptions and rising demand for care.

A study found that 34% of adolescents seeking treatment for cannabis use disorder (CUD) in 2022 faced admission delays, with wait times attributed to pandemic-related disruptions and increased demand. The research, analyzing data from 2012 to 2022, highlights growing challenges in accessing care for CUD among 12-17-year-olds.

A study found that 34% of adolescents seeking treatment for cannabis use disorder (CUD) in 2022 experienced delays in admission to care, with wait times peaking after the COVID-19 pandemic. The research, analyzing data from 2012 to 2022, linked increased delays to pandemic disruptions and higher demand for services.

A study published in the American Journal of Preventive Medicine found that nearly 34% of adolescents seeking treatment for cannabis use disorder in 2022 experienced admission delays. The increase in wait times followed several years of decline and may reflect pandemic-related disruptions and rising demand for care.

A 2022 study found nearly 34% of adolescents seeking treatment for cannabis use disorder (CUD) experienced admission delays, with wait times increasing sharply since 2015. The study, analyzing over 124,000 adolescent admissions between 2012 and 2022, linked the trend to pandemic-related disruptions and higher demand for care.

States debate stricter THC limits on cannabis products amid research linking high-potency cannabis to increased risks of psychosis and cannabis use disorder, particularly among adolescents and young adults. A Connecticut mother shares her son's decline after using cannabis for social anxiety, highlighting the challenges of addiction and mental health impacts.

High-potency cannabis products, including concentrates with over 80% THC, are fueling state debates over mental health risks like psychosis and addiction. Some states have introduced legislation to limit THC potency, while others resist due to industry opposition and uncertain research. A Connecticut mother's son developed cannabis use disorder after using high-THC cannabis to manage anxiety, leading to severe mental health decline.

High-potency cannabis products are fueling state debates over risks of psychosis and addiction, particularly among adolescents and young adults. States are considering stricter THC limits as research links frequent use of high-THC cannabis to mental health issues. A Connecticut mother shared her son’s decline after cannabis use led to cannabis use disorder and psychotic episodes.

High-THC cannabis products are linked to increased risks of psychosis and addiction, prompting state legislative debates over potency limits. States like Connecticut face cases of severe cannabis use disorder, particularly among adolescents and young adults, as lawmakers weigh stricter regulations against industry opposition.

A Connecticut mother describes her son's severe cannabis use disorder linked to high-THC products, prompting state debates over potency limits. Research suggests high-potency cannabis increases risks of psychosis and addiction, particularly among youth. Some states are imposing stricter THC caps while others resist due to industry pushback and research uncertainties.

High-potency cannabis products are fueling state debates over risks of psychosis and addiction, with some lawmakers proposing stricter THC limits. A Connecticut mother shared how her son developed cannabis use disorder and psychosis after using high-THC cannabis, highlighting concerns about health impacts. Research indicates frequent use of high-THC cannabis increases mental health risks, particularly for adolescents and young adults.

States debate stricter THC limits for cannabis products amid research linking high-potency cannabis to increased risks of psychosis and addiction, particularly among adolescents. A Connecticut mother shares her son's experience developing cannabis use disorder after using high-THC products, highlighting erratic behavior and mental health decline.

High-potency cannabis products are fueling debates over psychosis and addiction risks, with states considering stricter THC limits. A Connecticut mother describes her son's decline after cannabis use led to severe mental health issues and cannabis use disorder, highlighting growing concerns about the health impacts of legal, high-THC products.

High-potency cannabis products are fueling state debates over psychosis and addiction risks, with some lawmakers proposing stricter THC limits. A Connecticut mother describes her son's decline due to cannabis use disorder, highlighting concerns about mental health impacts, particularly among adolescents. Research links frequent high-THC use to increased risks of psychosis and addiction, while federal reclassification of medical marijuana has raised questions about public perception.

States are debating stricter THC limits on cannabis products due to rising concerns over psychosis and addiction risks linked to high-potency cannabis. A Connecticut mother describes her son's severe cannabis use disorder and erratic behavior after using cannabis to cope with anxiety, highlighting broader public health concerns. Research suggests frequent use of high-THC cannabis increases mental health risks, particularly for adolescents and young adults.